I don’t usually do financial news here, but I’m a Fool from way back, and I think it’s interesting that they’ve picked one of our companies to highlight.
Motley Fool’s CAPS community forums have picked Cray as one of 7 previously “unloved” stocks that it recommends investors check out. From the article:
So what’s making CAPS players reconsider Cray’s former one-star rating? A big reason for the shift is the $250 million DARPA contract that Cray announced it had won back in November.
Other companies highlighted include Seattle Genetics and Oncolytics Biotech.
Leave your own comment